Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment
Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Irritable Bowel Syndrome Treatment Market – Overview
The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the
condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable
bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these
symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are
distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life.
However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary,
lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be
treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely,
medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional
therapy by using fibers and probiotics or prebiotics depending on the situation.
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which
various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people
to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the
irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast
period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with
sensitivity towards certain foods and stress.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Irritable Bowel Syndrome Treatment Market Taxonomy:
By Drug Type:
●
Lubiprostone
●
Linaclotide
●
Eluxadoline
By Medical Condition:
●
IBS-Constipation
●
IBS-Diarrhea
By Distribution Channel:
●
Hospital Pharmacies
●
Online Pharmacies
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/506
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Irritable Bowel Syndrome Treatment Market: Key Players
●
Abbott Laboratories *.
●
Synergy Pharmaceuticals, Inc.
●
Sucampo Pharmaceuticals, Inc.
●
Valeant Pharmaceuticals International, Inc.
●
Ardelyx, Inc.
●
Astellas Pharma Inc.
●
Novartis AG
●
GlaxoSmithKline plc.
View this report @
https://www.coherentmarketinsights.com/market-insight/irritable-bowel-syndrome-treatment-market-506
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

Irritable bowel syndrome is a gastrointestinal tract disorder characterized by abdominal pain and altered bowel habits. It hampers the natural movement of intestinal muscle linings to move food along the digestive tract. Depending on the symptoms, the syndrome is distinguished as mild and severe irritable bowel syndrome.